Roland Eid

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 9

Top Topics

Nursing Students

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Metastatic Colorectal Cancer

Top Venues

Future oncology (London, England)

Biomarkers in medicine

Personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gaëlle Haddad, Marie Christelle Saadé, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie
PARP inhibitors: a tsunami of indications in different malignancies. Pharmacogenomics 21 (3) (2021)
Lynn Bitar, Joseph Zouein, Fady Gh Haddad, Roland Eid, Hampig R Kourie
HER2 in metastatic colorectal cancer: a new to target to remember. Biomarkers in medicine 15 (2) (2021)
Joseph Zouein, Fady Gh Haddad, Roland Eid, Hampig Raphaël Kourie
The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice. Immunotherapy (2021)
Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
In reply to: incorporating teleoncology practices in the undergraduate medical curriculum. Future oncology (London, England) 17 (1) (2020)
Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Michel Scheuer, Roland Tomb
Bioethical considerations for cancer patient care during the COVID-19 pandemic. Future oncology (London, England) 16 (34) (2020)
Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Marwan Ghosn, Dolla Karam Sarkis
The future of cancer research after COVID-19 pandemic: recession? Future oncology (London, England) 16 (21) (2020)
Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad
Agnostic biomarkers in gastrointestinal tumors: microsatellite instability and NTRK. Personalized medicine 18 (1) (2020)
Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities. Future oncology (London, England) 16 (18) (2020)
Elissar Moujaess, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review. Immunotherapy 11 (16) (2019)